Data Tables


Sections I - VIII
I. Summary Tables
II. Deceased and Living Donor Characteristics
III. Deceased Donor Organ Recovery and Disposition
IV. Organ Procurement Organization Tables
V. Kidney Tables
VI. Pancreas Transplant Alone (PTA) Tables
VII. Pancreas After Kidney (PAk) Tables
VIII. Kidney-Pancreas Tables
Sections IX - XV
IX. Liver Tables
X. Intestine Tables
XI. Heart Tables
XII. Lung Tables
XIII. Heart-Lung Tables
XIV. Donor and Recipient Tumor Tables
XV. Supplementary Tables
  Technical Notes and Analytic Methods
  All Data Tables (214 K)

View HTML View PDF

Section XIII
13.1aWaiting List Patient Characteristics at End of Year Heart-Lung Waiting List Active Waitlist Patients, 1995 to 2004Table 13.1a (42 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
13.1bWaiting List Patient Characteristics at End of Year Heart-Lung Waiting List Active and Inactive Patient Comparison, 2000 to 2004Table 13.1b (36 k)
Age
Diagnosis
Gender
Race
Time on Waiting List
13.2Time to Transplant, 1995 to 2004 New Heart-Lung Waiting List RegistrationsTable 13.2 (53 k)
Blood Type
Age
Gender
All Patient Types
Previous Transplant
Race
Residency
13.3Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1995 to 2004 Heart-Lung Waiting ListTable 13.3 (40 k)
Age
Blood Type
Gender
Race
13.4Transplant Recipient Characteristics, 1995 to 2004 Heart-Lung RecipientsTable 13.4 (42 k)
Age
Blood Type
Residency
Gender
Race
Diagnosis
On Life Support at TX
Hospitalized at Transplant
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
13.5Incidence of Transplant, 1995 to 2004 Heart-Lung Transplants per 1 Million PopulationTable 13.5 (29 k)
13.6aImmunosuppression Use for Induction, 1995 to 2004 Recipients with Heart-Lung TransplantsTable 13.6a (30 k)
13.6bImmunosuppression Use for Induction by Discharge Regimen, 2000 to 2004 Recipients with Heart-Lung TransplantsTable 13.6b (32 k)
13.6cImmunosuppression Use for Induction by Steroid Use at Discharge, 2000 to 2004 Recipients with Heart-Lung TransplantsTable 13.6c (29 k)
13.6dImmunosuppression Use for Maintenance by Regimen Prior to Discharge, 1995 to 2004 Recipients with Heart-Lung TransplantsTable 13.6d (30 k)
13.6eImmunosuppression Use for Maintenance Prior to Discharge, 1995 to 2004 Recipients with Heart-Lung TransplantsTable 13.6e (31 k)
13.6fImmunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1994 to 2003 Recipients with Heart-Lung TransplantsTable 13.6f (31 k)
13.6gImmunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1994 to 2003 Recipients with Heart-Lung TransplantsTable 13.6g (31 k)
13.6hPersistency of Discharge Regimen by Follow-up Period, 1999 to 2003 Recipients with Heart-Lung TransplantsTable 13.6h (30 k)
13.6iImmunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1994 to 2003 Recipients with Heart-Lung TransplantsTable 13.6i (30 k)
13.7Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1995 to 2003 Rates for Recipients during First Year after Heart-Lung TransplantationTable 13.7 (65 k)
Blood Type
Residency
Gender
Race
Age of Donor
Age
Cold Ischemia Time
On Life Support at TX
Hospitalized at Transplant
Previous Transplant
Diagnosis
13.8Adjusted Graft Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 13.8 (36 k)
Age
Gender
Race
Diagnosis
13.9Unadjusted Graft Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 13.9 (42 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Age of Donor
Previous Transplant Same Organ
Diagnosis
Cold Ischemia Time
On Life Support at TX
Hospitalized at Transplant
13.10Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, and 5 Years Heart-Lung TransplantsTable 13.10 (29 k)
13.11Adjusted Patient Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 13.11 (36 k)
Age
Gender
Race
Diagnosis
13.12Unadjusted Patient Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 13.12 (42 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Age of Donor
Diagnosis
Cold Ischemia Time
On Life Support at TX
Hospitalized at Transplant
13.13Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, and 5 Years Heart-Lung TransplantsTable 13.13 (29 k)
13.14Prevalence of People Living with a Functioning Transplant at End of Year Heart-Lung Recipients, 1995 to 2004Table 13.14 (41 k)
Blood Type
Residency
Gender
Race
Age
Diagnosis
On Life Support at TX
Hospitalized at Transplant
Previous Transplant Same Organ
Previous Transplant Any Organ
13.15Transplants by State and Transplant Center, 1995 to 2004 Heart-LungTable 13.15 (47 k)